Patient recruitment for infectious diseases & vaccination clinical trials
Patient recruitment for infectious diseases & vaccination clinical trials
Do your infectious disease and vaccination trials need a boost?
Recruiting for infectious diseases and vaccination trials presents unique challenges. Vaccine trials rely on a well-informed patient population, with the need to create easy-to-understand educational and informational materials to build patient trust and understanding. They require shifting strategies through the changing phases of trials, and most importantly the creation of safe and efficacious vaccines requires a diverse and representative patient population.
At Clariness, we have supported over 15 vaccine trials in recent years, from exceeding COVID-19 trial recruitment targets by 245% to doubling referral targets in a yellow fever trial, and exceeding targets in a difficult age-specific (65-70) study for Respiratory Syncytial Virus (RSV).
COVID-19
For a COVID-19 trial we supported, we surpassed our initial randomization goal by 245%. Do you want to learn how we can do the same for your trial?
Respiratory Syncytial Virus (RSV)
RSV can have significant impacts on infants and young children. This patient group typically presents slower recruitment times and limitations on trial participation. Do you want to know about our experience recruiting for pediatric trials?
Are you designing an infectious diease study, or have one underway?
We can help you find the right patients, at the right time. To find out more, contact us.